FORM 6-K


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


Report of Foreign Private Issuer
Pursuant to Rule 13a-16 under
the Securities Exchange Act of 1934


For the month ended July, 2012


ICON plc
(Registrant's name)


0-29714
(Commission file number)


South County Business Park, Leopardstown, Dublin 18, Ireland
(Address of principal executive offices)

Brendan Brennan, CFO
South County Business Park Leopardstown, Dublin 18, Ireland.
Brendan.Brennan@iconplc.com
0011-353-1-291-2000
(Name, telephone number, email and/or facsmile number and address of Company contact person)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

              Yes___X___                                   No_______

Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

              Yes______                                    No___X___

Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

              Yes______                                    No___X___

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

              Yes_______                                   No___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):82      N/A


EXHIBIT LIST

Exhibit

 

Description

 

99.1

Icon plc Press Release announcement issued July 24, 2012.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ICON plc

 
 
 

 

Date:

July 24, 2012

/s/ Brendan Brennan

Brendan Brennan

Chief Financial Officer

Exhibit 99.1

ICON Reports second quarter 2012 revenue up 19% to $277 million and non-GAAP EPS of 21c (NASDAQ:ICLR) (ISIN:IE0005711209)

Highlights – Second Quarter Fiscal 2012

* Net revenue of $277 million, a 19% increase year on year.

* Income from operations, excluding restructuring and other non-recurring items, was $16.6 million or 6% of revenue.

* EPS, excluding restructuring and other non-recurring items, was 21 cents.

* Gross business wins were $477 million, representing a gross book to bill of 1.7, Net business wins were $373 million, representing a net book to bill of 1.35.

DUBLIN--(BUSINESS WIRE)--July 24, 2012--ICON (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter ended June 30, 2012.

Net revenue for the quarter was $277 million, an increase of 19% on the prior year. Year to date revenue increased 15% to $529 million from $462 million in 2011.

Income from operations, excluding restructuring and other non-recurring items, was $16.6 million or 6.0% of revenue, compared to $15.5 million or 6.7% for the same quarter last year. Net income, excluding restructuring and other non-recurring items, was $12.9 million or 21 cents per share on a diluted basis, compared with $13.1 million or 21 cents per share last year.

Year to date income from operations, excluding restructuring and other non-recurring items was $28.4 million or 5.4% of revenue, compared with $31.5m or 6.8% of revenue in the previous year. Year to date net income, excluding restructuring and other non-recurring items, was $21.9 million or 36 cents per share on a diluted basis, compared with $25.9 million or 42 cents per diluted share last year.

Days sales outstanding, comprising accounts receivable and unbilled revenue less payments on account, were 36 days at June 30, 2012, compared with 37 days at the end of March 2012.

For the quarter ended June 30, 2011, cash generated from operating activities was $11.5 million and capital expenditure was $9.3 million. The company’s net cash amounted to $168 million at June 30, 2012, compared to net cash of $186 million at March 31, 2012.

Commenting on the results, Chief Executive Officer, Ciaran Murray, said “I am pleased with our progress in Q2. We continue to book significant levels of new business and improve our profitability.”

During the quarter the company recorded a charge of $5.6 million in relation to restructuring costs and other non-recurring items. US GAAP income from operations after these items amounted to $11 million or 4.0% of revenue. US GAAP net income for the quarter was $8 million or 13 cents per share.

In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), this press release contains certain non-GAAP financial measures, including non-GAAP operating and net income and non-GAAP diluted earnings per share. While non-GAAP financial measures are not superior to or a substitute for the comparable GAAP measures, ICON believes certain non-GAAP information is useful to investors for historical comparison purposes.


The company will hold its second quarter conference call today, July 24, 2012 at 9:00 EST [14:00 Ireland & UK]. This call and linked slide presentation can be accessed live from our website at http://www.iconplc.com. A recording will also be available on the website for 90 days following the call. In addition, a calendar of company events, including upcoming conference presentations, is available on our website, under “Investors”. This calendar will be updated regularly.

The statements made in this Press Release may contain forward-looking statements that involve a number of risks and uncertainties. In addition to the matters described in this Press Release, the ability to maintain large client contracts or enter into new contracts, maintain client relationships and the ability to manage the opening of new offices, the integration of new business mergers and acquisitions, as well as other risks and uncertainties detailed from time to time in SEC reports filed by ICON, including its Form 20-F, F-1, S-8 and F-3, may affect the actual results achieved by ICON. ICON disclaims any intent or obligation to update these forward-looking statements.

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 82 locations in 40 countries and has approximately 8,930 employees. Further information is available at www.iconplc.com.

ICON/ICLR-F


   
 
ICON plc
 

Consolidated Income Statements (Unaudited)
(Before restructuring and other non-recurring items)

 
Three Months ended June 30, 2012 and June 30, 2011
(Dollars, in thousands, except share and per share data)
 
 
Three Months Ended
June 30, June 30,
2012 2011
 
Gross Revenue 379,620 317,696
 
Reimbursable expenses 102,613 84,651
   
Net Revenue 277,007 233,045
 
Costs and expenses
Direct costs 180,127 150,866
Selling, general and administrative 69,410 57,344
Depreciation and amortization 10,830 9,329
   
Total costs and expenses 260,367 217,539
 
Income from operations 16,640 15,506
 
Net interest (expense)/income (231) 106
   
Income before provision for income taxes 16,409 15,612
 
Provision for income taxes 3,514 2,530
Net income 12,895 13,082
 
Net income per ordinary share
Basic $0.21 $0.22
 
Diluted $0.21 $0.21
 
Weighted average number of ordinary shares
Basic 59,978,509 60,390,788
 
Diluted 60,630,891 61,114,996

   
 
ICON plc
 
Consolidated Income Statements (Unaudited) (US GAAP)
 
Three Months ended June 30, 2012 and June 30, 2011
(Dollars, in thousands, except share and per share data)
 
 
Three Months Ended
June 30, June 30,
2012 2011
 
Gross Revenue 379,620 317,696
 
Reimbursable expenses 102,613 84,651
   
Net Revenue 277,007 233,045
 
Costs and expenses
Direct costs 180,127 150,866
Selling, general and administrative 69,410 57,344
Depreciation and amortization 10,830 9,329
Restructuring and other non-recurring items 5,636 -
Total costs and expenses 266,003 217,539
 
Income from operations 11,004 15,506
 
Net interest (expense)/income (231) 106
   
Income before provision for income taxes 10,773 15,612
 
Provision for income taxes 2,809 2,530
Net income 7,964 13,082
 
Net income per ordinary share
Basic $0.13 $0.22
 
Diluted $0.13 $0.21
 
Weighted average number of ordinary shares
Basic 59,978,509 60,390,788
 
Diluted 60,630,891 61,114,996

             

ICON plc

 
Summary Balance Sheet Data
 
 
June 30, 2012 and December 31, 2011
(Dollars, in thousands)
 
June 30, December 31,
2012 2011
(Unaudited) (Audited)
Cash and short-term investments 168,038 174,177
 
Accounts receivable 228,215 201,338
Unbilled revenue 115,407 126,850
Payments on account (194,514) (150,792)
Total 149,108 177,396
 
Working Capital 197,589 253,514
 
Total Assets 1,104,894 1,035,467
 
Shareholder's Equity 683,601 681,544

CONTACT:
ICON plc
Investor Relations
1-888-381-7923
or
Brendan Brennan Chief Financial Officer
+ 353 –1-291-2000
or
Sam Farthing VP Investor Relations
+ 353 –1-291-2000
http://www.iconplc.com